文献速递关节外科创伤骨科

复发性全膝关节置换术后假体周围感染治疗失败后的生活质量与结局:经股骨截肢、关节融合与永久性间隔物的多中心回顾性比较

Quality of Life and Outcomes After Treatment Failure for Recurrent Periprosthetic Joint Infection of Total Knee Arthroplasty: A Multicenter Retrospective Comparison of Transfemoral Amputation, Arthrodesis, and Permanent Spacer.
PubMed 文献 · J Arthroplasty · 2025-08-19

该多中心回顾性研究纳入2013年1月至2024年12月在波尔多大学医院和南特大学医院因反复全膝关节置换术后感染行膝上截肢、永久性间隔物或膝关节融合的患者,比较其生活质量和术后结局。结果显示膝上截肢组在Short Form-36多个维度、VAS和DN4评分上优于永久性间隔物组和关节融合组。作者认为膝上截肢不仅可作为最后手段,也可作为特定患者的选择。

要点

  • 膝上截肢组Short Form-36总体健康评分48.8±19.8,优于永久性间隔物组和关节融合组(P=0.014)。
  • 膝上截肢组VAS评分1.96±1.26、DN4评分1.78±1.04,优于间隔物组和融合组(P=0.002和0.023)。
  • 作者认为膝上截肢不仅可作为最后手段,也可作为特定患者的可行选择。

核心结论

  • 作者认为膝上截肢相比永久性间隔物提供更好的疼痛缓解、更少的并发症和更优的生活质量。
  • 作者认为这些结果支持将膝上截肢不仅视为最后手段,也视为特定患者的可行选择。

研究设计与样本

  • 多中心回顾性研究,纳入2013年1月至2024年12月在波尔多大学医院和南特大学医院因反复全膝关节置换术后感染行膝上截肢、永久性间隔物或膝关节融合的患者。
  • 永久性间隔物组43例,膝上截肢组35例,关节融合组8例。
  • 所有患者接受Short Form-36评分、视觉模拟量表(VAS)评分、Douleur Neuropathique 4(DN4)评分和功能评估。

主要发现

  • 膝上截肢组Short Form-36总体健康评分为48.8±19.8,优于永久性间隔物组和关节融合组(P=0.014)。
  • 膝上截肢组因身体健康导致的角色限制评分为26.7±34.1,优于永久性间隔物组和关节融合组(P=0.002)。
  • 膝上截肢组疼痛评分为51.6±31.6,优于永久性间隔物组和关节融合组(P=0.088)。
  • 膝上截肢组VAS评分为1.96±1.26,永久性间隔物组为3.83±1.98,关节融合组为3.67±1.37(P=0.002)。
  • 膝上截肢组DN4评分为1.78±1.04,永久性间隔物组为2.79±1.18,关节融合组为2.33±1.63(P=0.023)。

临床怎么用

  • 作者认为膝上截肢不仅可作为最后手段,也可作为特定患者的可行选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In cases of recurrent treatment failure for periprosthetic joint infections of the knee, above-the-knee amputation (AKA), knee arthrodesis, or permanent spacers are viable. Given the limited comparative data on outcomes between AKA and knee arthrodesis, as well as the lack of data on a permanent spacer, we conducted a retrospective study to evaluate and compare the quality of life and postoperative outcomes. METHODS: All patients who had an AKA, a permanent spacer, or knee arthrodesis for repeated total knee arthroplasty infections at the Bordeaux University Hospital and Nantes University Hospital between January 2013 and December 2024 were included. There were 43 patients in the permanent spacer group, 35 in the AKA group, and eight in the arthrodesis group. All patients underwent the Short Form-36 score, visual analog scale (VAS) score, Douleur Neuropathique 4 (DN4) score, and functional assessment. RESULTS: The AKA group showed significantly better outcomes in Short Form-36 scores, including general health (48.8 ± 19.8; P = 0.014), role limitations due to physical health (26.7 ± 34.1; P = 0.002), and pain (51.6 ± 31.6; P = 0.088), compared to the permanent spacer and arthrodesis groups. The VAS and DN4 scores were significantly better in the AKA group (1.96 ± 1.26 and 1.78 ± 1.04) compared to the spacer group (VAS: 3.83 ± 1.98, DN4: 2.79 ± 1.18) and arthrodesis group (VAS: 3.67 ± 1.37, DN4: 2.33 ± 1.63) with P = 0.002 and 0.023, respectively. CONCLUSIONS: Our findings suggest that AKA provides better pain relief, fewer complications, and superior quality of life compared to a permanent spacer. These results support considering AKA not only as a last-resort option but as a viable alternative in selected patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Huguet R, Fabre T, Crenn V, et al. Quality of Life and Outcomes After Treatment Failure for Recurrent Periprosthetic Joint Infection of Total Knee Arthroplasty: A Multicenter Retrospective Comparison of Transfemoral Amputation, Arthrodesis, and Permanent Spacer. J Arthroplasty. 2025. PMID: 40840660. doi:10.1016/j.arth.2025.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。